Relation between hepatic and renal function tests and ultrastructural changes induced by 2- N -methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579), a new experimental antileukemic drug
Identifieur interne : 003A12 ( Main/Exploration ); précédent : 003A11; suivant : 003A13Relation between hepatic and renal function tests and ultrastructural changes induced by 2- N -methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579), a new experimental antileukemic drug
Auteurs : A. Ghys [Belgique] ; O. Thys [Belgique] ; J. Hildebrand [Belgique] ; A. Georges [Belgique]Source :
- Toxicology and Applied Pharmacology [ 0041-008X ] ; 1975.
English descriptors
- Teeft :
- Alkaline phosphatase, Analytical chemistry, Bilirubin, Bone marrow, Clin, Control groups, Control rats, Electron microscopy, Electrophoretic pattern, Experimental antileukemic drug, Glutamic pyruvic transaminase, Hepatic, Hepatic function, Hildebrand, Kinetic photometric method, Lamellar material, Lamellate cytosomes, Leucine aminopeptidase, Liver lysosomes, Liver weight, Prothrombin, Prothrombin time, Recovery period, Renal, Renal function tests, Single determinations, Statistical differences, Test rats, Thys, Total cholesterol, Total proteins, Total serum proteins, Treatment period, Ultrastructural, Ultrastructural study, Uric acid.
Abstract
Abstract: The toxicity of 2-N-methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579, NSC-170561) was investigated in Sprague-Dawley rats. The drug was administered po at a daily dose of 500 mg/kg for 30 days. The drug reduced feed intake, lowered average body weight, and produced a marked increase in liver weight. Ultrastructural study of hepatocytes showed an increase of smooth endoplasmic reticulum and the presence of numerous lysosomes overloaded with lamellar material. Lamellate cytosomes were also seen in kidney convoluted tubule cells. In contrast with the striking morphologic alterations observed in hepatocytes, the results of tests of hepatic function performed at the end of the treatment did not differ markedly from controls except for a 42-fold increase in the activity of γ-glutamyl-transpeptidase and a mild increase in the activities of ornithine carbamyl transferase and glutamic pyruvic transaminase. Urea nitrogen was elevated slightly, but creatinine and uric acid were similar for test and control animals. There was practically no effect on blood elements. Most of the observed changes were reversible.
Url:
DOI: 10.1016/0041-008X(75)90047-2
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001D53
- to stream Istex, to step Curation: 001D53
- to stream Istex, to step Checkpoint: 002756
- to stream Main, to step Merge: 003A92
- to stream Main, to step Curation: 003A12
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Relation between hepatic and renal function tests and ultrastructural changes induced by 2- N -methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579), a new experimental antileukemic drug</title><author><name sortKey="Ghys, A" sort="Ghys, A" uniqKey="Ghys A" first="A." last="Ghys">A. Ghys</name></author><author><name sortKey="Thys, O" sort="Thys, O" uniqKey="Thys O" first="O." last="Thys">O. Thys</name></author><author><name sortKey="Hildebrand, J" sort="Hildebrand, J" uniqKey="Hildebrand J" first="J." last="Hildebrand">J. Hildebrand</name></author><author><name sortKey="Georges, A" sort="Georges, A" uniqKey="Georges A" first="A." last="Georges">A. Georges</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:EEE4C92B6ADDB22082E557497FB7B71EFD6F1203</idno><date when="1975" year="1975">1975</date><idno type="doi">10.1016/0041-008X(75)90047-2</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-V6X0888F-7/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001D53</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D53</idno><idno type="wicri:Area/Istex/Curation">001D53</idno><idno type="wicri:Area/Istex/Checkpoint">002756</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002756</idno><idno type="wicri:doubleKey">0041-008X:1975:Ghys A:relation:between:hepatic</idno><idno type="wicri:Area/Main/Merge">003A92</idno><idno type="wicri:Area/Main/Curation">003A12</idno><idno type="wicri:Area/Main/Exploration">003A12</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Relation between hepatic and renal function tests and ultrastructural changes induced by 2- N -methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579), a new experimental antileukemic drug</title><author><name sortKey="Ghys, A" sort="Ghys, A" uniqKey="Ghys A" first="A." last="Ghys">A. Ghys</name><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Département de Recherche, A. Christiaens, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire d'Anatomie Pathologique et de Microscopie Electronique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire de Médecine Expérimentale, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Médecine et d'Investigation Clinique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Belgique</country><wicri:regionArea>1 A. Christiaens, Société Anonyme, 60, rue de l'Etuve, B-1000 Brussels</wicri:regionArea><wicri:noRegion>B-1000 Brussels</wicri:noRegion></affiliation></author><author><name sortKey="Thys, O" sort="Thys, O" uniqKey="Thys O" first="O." last="Thys">O. Thys</name><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Département de Recherche, A. Christiaens, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire d'Anatomie Pathologique et de Microscopie Electronique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire de Médecine Expérimentale, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Médecine et d'Investigation Clinique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Hildebrand, J" sort="Hildebrand, J" uniqKey="Hildebrand J" first="J." last="Hildebrand">J. Hildebrand</name><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Département de Recherche, A. Christiaens, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire d'Anatomie Pathologique et de Microscopie Electronique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire de Médecine Expérimentale, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Médecine et d'Investigation Clinique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author><author><name sortKey="Georges, A" sort="Georges, A" uniqKey="Georges A" first="A." last="Georges">A. Georges</name><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Département de Recherche, A. Christiaens, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire d'Anatomie Pathologique et de Microscopie Electronique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratoire de Médecine Expérimentale, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Belgique</country><wicri:regionArea>Service de Médecine et d'Investigation Clinique, Institut Jules Bordet, Université de Bruxelles, Bruxelles</wicri:regionArea><placeName><settlement type="city">Bruxelles</settlement><region nuts="2">Région de Bruxelles-Capitale</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Toxicology and Applied Pharmacology</title><title level="j" type="abbrev">YTAAP</title><idno type="ISSN">0041-008X</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1975">1975</date><biblScope unit="volume">31</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="13">13</biblScope><biblScope unit="page" to="20">20</biblScope></imprint><idno type="ISSN">0041-008X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0041-008X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Alkaline phosphatase</term><term>Analytical chemistry</term><term>Bilirubin</term><term>Bone marrow</term><term>Clin</term><term>Control groups</term><term>Control rats</term><term>Electron microscopy</term><term>Electrophoretic pattern</term><term>Experimental antileukemic drug</term><term>Glutamic pyruvic transaminase</term><term>Hepatic</term><term>Hepatic function</term><term>Hildebrand</term><term>Kinetic photometric method</term><term>Lamellar material</term><term>Lamellate cytosomes</term><term>Leucine aminopeptidase</term><term>Liver lysosomes</term><term>Liver weight</term><term>Prothrombin</term><term>Prothrombin time</term><term>Recovery period</term><term>Renal</term><term>Renal function tests</term><term>Single determinations</term><term>Statistical differences</term><term>Test rats</term><term>Thys</term><term>Total cholesterol</term><term>Total proteins</term><term>Total serum proteins</term><term>Treatment period</term><term>Ultrastructural</term><term>Ultrastructural study</term><term>Uric acid</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: The toxicity of 2-N-methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579, NSC-170561) was investigated in Sprague-Dawley rats. The drug was administered po at a daily dose of 500 mg/kg for 30 days. The drug reduced feed intake, lowered average body weight, and produced a marked increase in liver weight. Ultrastructural study of hepatocytes showed an increase of smooth endoplasmic reticulum and the presence of numerous lysosomes overloaded with lamellar material. Lamellate cytosomes were also seen in kidney convoluted tubule cells. In contrast with the striking morphologic alterations observed in hepatocytes, the results of tests of hepatic function performed at the end of the treatment did not differ markedly from controls except for a 42-fold increase in the activity of γ-glutamyl-transpeptidase and a mild increase in the activities of ornithine carbamyl transferase and glutamic pyruvic transaminase. Urea nitrogen was elevated slightly, but creatinine and uric acid were similar for test and control animals. There was practically no effect on blood elements. Most of the observed changes were reversible.</div></front></TEI><affiliations><list><country><li>Belgique</li></country><region><li>Région de Bruxelles-Capitale</li></region><settlement><li>Bruxelles</li></settlement></list><tree><country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Ghys, A" sort="Ghys, A" uniqKey="Ghys A" first="A." last="Ghys">A. Ghys</name></region><name sortKey="Georges, A" sort="Georges, A" uniqKey="Georges A" first="A." last="Georges">A. Georges</name><name sortKey="Georges, A" sort="Georges, A" uniqKey="Georges A" first="A." last="Georges">A. Georges</name><name sortKey="Georges, A" sort="Georges, A" uniqKey="Georges A" first="A." last="Georges">A. Georges</name><name sortKey="Georges, A" sort="Georges, A" uniqKey="Georges A" first="A." last="Georges">A. Georges</name><name sortKey="Ghys, A" sort="Ghys, A" uniqKey="Ghys A" first="A." last="Ghys">A. Ghys</name><name sortKey="Ghys, A" sort="Ghys, A" uniqKey="Ghys A" first="A." last="Ghys">A. Ghys</name><name sortKey="Ghys, A" sort="Ghys, A" uniqKey="Ghys A" first="A." last="Ghys">A. Ghys</name><name sortKey="Ghys, A" sort="Ghys, A" uniqKey="Ghys A" first="A." last="Ghys">A. Ghys</name><name sortKey="Hildebrand, J" sort="Hildebrand, J" uniqKey="Hildebrand J" first="J." last="Hildebrand">J. Hildebrand</name><name sortKey="Hildebrand, J" sort="Hildebrand, J" uniqKey="Hildebrand J" first="J." last="Hildebrand">J. Hildebrand</name><name sortKey="Hildebrand, J" sort="Hildebrand, J" uniqKey="Hildebrand J" first="J." last="Hildebrand">J. Hildebrand</name><name sortKey="Hildebrand, J" sort="Hildebrand, J" uniqKey="Hildebrand J" first="J." last="Hildebrand">J. Hildebrand</name><name sortKey="Thys, O" sort="Thys, O" uniqKey="Thys O" first="O." last="Thys">O. Thys</name><name sortKey="Thys, O" sort="Thys, O" uniqKey="Thys O" first="O." last="Thys">O. Thys</name><name sortKey="Thys, O" sort="Thys, O" uniqKey="Thys O" first="O." last="Thys">O. Thys</name><name sortKey="Thys, O" sort="Thys, O" uniqKey="Thys O" first="O." last="Thys">O. Thys</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A12 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A12 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:EEE4C92B6ADDB22082E557497FB7B71EFD6F1203
|texte= Relation between hepatic and renal function tests and ultrastructural changes induced by 2- N -methylpiperazinomethyl-1,3-diazafluoranthen 1-oxide (AC-3579), a new experimental antileukemic drug
}}
| This area was generated with Dilib version V0.6.33. |  |